About TMiRob
TMiRob is a company based in Shanghai (China) founded in 2015 by Pan Jing. TMiRob has raised $37.2 million across 4 funding rounds from investors including ECOVACS Robotics, Shanghai Zhangjiang Hi-Tech Park Development and Spinnotec. TMiRob operates in a competitive market with competitors including Blue Ocean Robotics, Clearpath Robotics, Capra Robotics, Xenex and Gideon, among others.
- Headquarter Shanghai, China
- Founders Pan Jing
-
Sectors
HealthcareIndustrial Goods & Manufacturing
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$37.2 M (USD)
in 4 rounds
-
Latest Funding Round
Not available
-
Investors
ECOVACS Robotics
& 7 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of TMiRob
TMiRob has successfully raised a total of $37.2M across 4 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in TMiRob
TMiRob has secured backing from 8 investors, including venture fund and institutional investors. Prominent investors backing the company include ECOVACS Robotics, Shanghai Zhangjiang Hi-Tech Park Development and Spinnotec.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
Investments are provided by GP Capital to financial services companies.
|
Locked | Locked | Locked |
Investor details for TMiRob
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by TMiRob
Investment portfolio details for TMiRob
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - TMiRob
Detailed financials for TMiRob
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Tmirob Comparisons
Peer comparison for TMiRob
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of TMiRob
TMiRob operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Blue Ocean Robotics, Clearpath Robotics, Capra Robotics, Xenex and Gideon, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Mobile robots are manufactured for industries including healthcare and agriculture.
|
|
| Locked | Locked | Locked |
Autonomous robots and software are provided for diverse industries.
|
|
| Locked | Locked | Locked |
UGVs for outdoor activities and surveillance are provided.
|
|
| Locked | Locked | Locked |
Disinfection robots with UV technology are supplied for healthcare sterilization.
|
|
| Locked | Locked | Locked |
Autonomous mobile robots for material handling are provided by Gideon.
|
|
| Locked | Locked | Locked |
Wheeled-legged robots with AI-based autonomy are developed for robotics engineering.
|
Detailed competitors of TMiRob
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Tmirob
Complete news archive for TMiRob
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about TMiRob
TMiRob was founded in 2015 and raised its 1st funding round 1 year after it was founded.
TMiRob is headquartered in Shanghai, China.
TMiRob is a funded company, having raised a total of $37.2M across 4 funding rounds to date.
TMiRob was founded in 2015 in Shanghai, China, focusing on robotics within the healthcare and industrial sectors. Autonomous navigation systems, equipped with sensors for obstruction avoidance, SLAM, and human interaction, are integrated into generic robotic chassis. Nosocomial infection control devices utilize artificial intelligence alongside ultraviolet light, ultra-dry atomized hydrogen peroxide, and air filtration to target pathogens. Additional offerings include service robots for nuclear medicine wards and intelligent logistics for laboratories.
TMiRob's top competitors include Blue Ocean Robotics, Clearpath Robotics and Gideon.
TMiRob has 8 investors. Key investors include ECOVACS Robotics, Shanghai Zhangjiang Hi-Tech Park Development, Spinnotec, Cantor Jungle, and GP Capital.